Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Dec 17;174(2):401–412. doi: 10.1007/s10549-018-05087-7

Figure 4: ER S118P cells remain sensitive to tamoxifen and fulvestrant.

Figure 4:

MCF7 cells and all targeted cell line derivatives were treated with 1 nM E2 and indicated concentrations of fulvestrant (A) or tamoxifen (B) over nine days. T47D cells and all targeted cell line derivatives were treated with 1 nM E2 and indicated concentrations of fulvestrant (C) or tamoxifen (D) over nine days. Data are shown as mean + SD of three replicates relative to cells treated with 1 nM E2 + vehicle, and graphs are representative of three independent experiments.